Investigating Potential Claims – ContraVir Pharmaceuticals
Are you concerned about your investment in ContraVir Pharmaceuticals? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) is a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of hepatitis B virus (HBV).
According to a press announcement in August, the company continues to assess strategic alternatives to assist in the research and funding for advancement of its two clinical programs.
“The company continues to carry discussions with potential partners both in the U.S. and internationally. While there are no guarantees for a partnership deal to come to fruition, ContraVir remains hopeful in finding the right partner who will have a shared commitment in the search for an HBV cure.”
Free Consultation with a Securities Attorney
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high risk investments, like ContraVir Pharmaceuticals to investors.
Brokerage firms are required to perform due diligence on any offering they recommend and to ensure that all recommendations made are suitable in light of the client’s age, investment experience, net worth, income, and investment objectives.
If a firm fails to perform due diligence or makes an unsuitable recommendation, the broker-dealer can be held responsible for any losses in a FINRA arbitration claim.
FINRA can help resolve problems and disputes through two non-judicial proceedings: arbitration and mediation. FINRA’s Dispute Resolution forum handles nearly all of the securities-related arbitrations and mediations in the United States.
If you have concerns regarding your investment in ContraVir Pharmaceuticals and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: ContraVir Pharmaceuticals complaints, ContraVir Pharmaceuticals help, ContraVir Pharmaceuticals high commissions, ContraVir Pharmaceuticals information, ContraVir Pharmaceuticals investigation, ContraVir Pharmaceuticals investment, ContraVir Pharmaceuticals investment losses, ContraVir Pharmaceuticals investor relations, ContraVir Pharmaceuticals investors, ContraVir Pharmaceuticals losses, ContraVir Pharmaceuticals ppm, ContraVir Pharmaceuticals prospectus, ContraVir Pharmaceuticals recovery options, ContraVir Pharmaceuticals risk, ContraVir Pharmaceuticals stock information, ContraVir Pharmaceuticals update Last modified: October 10, 2018